Kronos Bio, Inc. Quarterly Debt-to-equity in % from Q2 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Kronos Bio, Inc. quarterly Debt-to-equity history and growth rate from Q2 2021 to Q3 2024.
  • Kronos Bio, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 34 %, a 25.6% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 34 +6.93 +25.6% Sep 30, 2024
Q2 2024 33.6 +10.1 +42.9% Jun 30, 2024
Q1 2024 32 +11.3 +54.8% Mar 31, 2024
Q4 2023 30.6 +12.9 +72.9% Dec 31, 2023
Q3 2023 27.1 +11.2 +70.2% Sep 30, 2023
Q2 2023 23.5 +9.26 +65% Jun 30, 2023
Q1 2023 20.7 +7.78 +60.4% Mar 31, 2023
Q4 2022 17.7 +6.2 +54% Dec 31, 2022
Q3 2022 15.9 +5.2 +48.7% Sep 30, 2022
Q2 2022 14.2 -13.8 -49.2% Jun 30, 2022
Q1 2022 12.9 Mar 31, 2022
Q4 2021 11.5 Dec 31, 2021
Q3 2021 10.7 Sep 30, 2021
Q2 2021 28 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.